Open Access Policy

The Journal of Antibiotic Development and Clinical Practice (JADCP) is committed to ensuring that high-quality research is accessible to a global audience without financial or technical barriers. This aligns with our mission to advance knowledge and innovation in antibiotic research and clinical practice, enabling the rapid dissemination of impactful research findings.

Definition of Open Access

Open access allows unrestricted online access to peer-reviewed scholarly research, ensuring that articles are freely available to anyone, anywhere in the world. Open access enhances the visibility, accessibility, and impact of research by removing subscription fees or paywalls that may limit access to scientific knowledge.

Licensing and Rights

All articles published in JADCP are distributed under the Creative Commons Attribution (CC BY) license. This license permits:

• Unrestricted Use: Users are free to read, download, copy, distribute, print, and share the article in any medium or format.
• Adaptation: Articles can be remixed, transformed, or built upon, provided the original authors and source are appropriately credited.
• Attribution: Proper acknowledgment of the authorship and citation of the work must be included in all reproductions or adaptations.

This ensures that authors retain copyright while granting users the freedom to disseminate and utilize their research for both academic and non-commercial purposes.

Benefits of Open Access

1. Global Visibility:
   Articles published under open access are indexed in major databases and freely accessible worldwide, increasing the reach and impact of the research.

2. Higher Citations:
   Studies have shown that open-access articles are cited more frequently than subscription-based articles due to their unrestricted availability.

3. Collaborative Opportunities:
   By ensuring accessibility, open access fosters global collaboration among researchers, clinicians, and policymakers in the field of antibiotic development.

4. Public Engagement:
   Open access ensures that research is accessible to non-academic audiences, including healthcare practitioners, educators, and the general public, contributing to informed decision-making and public health initiatives.

Article Processing Charges (APCs)

To support the open-access publication model, JADCP charges an Article Processing Charge (APC) for accepted manuscripts. The APC covers:

• Editorial processing and peer review.
• Typesetting, formatting, and production.
• Hosting and long-term archiving of the article.

Fee Waivers and Discounts:

• Authors from low- and middle-income countries may apply for fee waivers or discounts, ensuring inclusivity and support for researchers with limited financial resources.
• Fee waiver applications are reviewed on a case-by-case basis.

Archiving and Preservation

All published articles are permanently archived in the journal’s Journal Management System (JMS) and supported by long-term digital preservation solutions. Articles remain accessible even in cases of unforeseen disruptions to the journal's operations.

Compliance with Open Access Mandates

The JADCP open-access policy complies with the mandates of funding agencies, institutions, and governments that require publicly funded research to be freely accessible. Authors can deposit their published articles in institutional repositories or other recognized archives without restrictions.

Author Rights

Authors retain full copyright over their work and have the right to:

• Share their research on personal or institutional websites.
• Disseminate their work to peers, students, and collaborators.
• Use their research for educational and research purposes.

Conclusion

The open-access policy of JADCP reflects our commitment to advancing knowledge, fostering collaboration, and supporting equitable access to scientific research. By removing barriers to access, we aim to empower researchers, practitioners, and the global community in their efforts to address critical challenges in antibiotic development and clinical practice.